EUVIMEDEUVIMED entdecken
Crossref

A 2B Protein‐Derived Peptide Effectively Inhibits Coxsackievirus B3 Infection

Chen Yuan iD, Jingying Zhou, Luna Yuan, Ruru Dong, Xiyan Yang, Siyu Li, Jinchang Liu, Jingqi Wu, Yao Wang, Yang Chen, Lexun Lin, Guangtian Wang und 5 weitere

The FASEB Journal · 2025

DOI: 10.1096/fj.202500209r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Chen Yuan und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Sixth Affiliated Hospital, Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Enterovirus B, Human, Coxsackievirus Infections, Peptides, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nonstructural 2B protein of coxsackievirus B (CVB) is a transmembrane protein that forms a hydrophilic tetramer viroporin on the cellular membrane structures. 2B plays a key role in the replication of CVB. We hypothesized that blocking the polymerization of 2B may interfere with CVB replication. In this study, a 2B‐derived peptide 2B 37‐50 demonstrated potent anti‐CVB3 activity in vitro. A Tat‐fused 2B 37‐50 (Tat‐2B 37‐50 ) showed significant inhibitory effects on the viral protein expression, RNA synthesis, and replication of CVB3. Tat‐2B 37‐50 treatment elicited a strong in vivo protective efficacy for the myocardial infection caused by CVB3. Tat‐2B 37‐50 was also effective against the infection of enterovirus A71 and coxsackievirus A16. Taken together, Tat‐2B 37‐50 has the potential to be a novel peptide drug for the treatment of CVB infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterovirus B, HumanCoxsackievirus InfectionsPeptidesAntiviral AgentsAnimalsHumansVirus ReplicationMice

Stichwörter der Autor:innen

2B proteinantiviral peptidecoxsackievirus Benteroviruseshydrophilic tetramer

Substanzen

PeptidesAntiviral Agents

Autor:innen und Institutionen

  • The Sixth Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Department of Microbiology, Harbin Medical University, Harbin, China.
  • Department of Cell Biology, Harbin Medical University, Harbin, China.
  • Wu Lien-Teh Biomedical Innovation Institute, Harbin Medical University, Harbin, China.

ORCID-Profile: Chen Yuan, Zhaohua Zhong

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Yuan, C., Zhou, J., Yuan, L., Dong, R., Yang, X., Li, S., Liu, J., Wu, J., Wang, Y., Chen, Y., Lin, L., Wang, G., Cui, Q., Wang, Y., Zhao, W., Li, Z., & Zhong, Z. (2025). A 2B Protein‐Derived Peptide Effectively Inhibits Coxsackievirus B3 Infection. The FASEB Journal. https://doi.org/10.1096/fj.202500209r

Vancouver

Yuan C, Zhou J, Yuan L, Dong R, Yang X, Li S, et al. A 2B Protein‐Derived Peptide Effectively Inhibits Coxsackievirus B3 Infection. The FASEB Journal. 2025. doi:10.1096/fj.202500209r

BibTeX
@article{Yuan2025,
  author = {Yuan, Chen and Zhou, Jingying and Yuan, Luna and Dong, Ruru and Yang, Xiyan and Li, Siyu and Liu, Jinchang and Wu, Jingqi and Wang, Yao and Chen, Yang and Lin, Lexun and Wang, Guangtian and Cui, Qingbo and Wang, Yan and Zhao, Wenran and Li, Zhaozhu and Zhong, Zhaohua},
  title = {A 2B Protein‐Derived Peptide Effectively Inhibits Coxsackievirus B3 Infection},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500209r}
}
Kostenlos starten →